Polymers, scaffolds and bioactive molecules with therapeutic properties in osteochondral pathologies: what’s new?

References

• Hunziker EB, Quinn TM, Hauselmann HJ. Quantitative structural organization of normal adult human articular cartilage. Osteoarthritis Cartilage. 2002;10:564–572.
   PubMed Web of Science ®Google Scholar
• Pearle AD, Warren RF, Rodeo SA. Basic science of articular cartilage and osteoarthritis. Clin Sports Med. 2005;24:1–12.
   PubMed Web of Science ®Google Scholar
• Nukavarapu SP, Dorcemus DL. Osteochondral tissue engineering: current strategies and challenges. Biotechnol Adv. 2013;31:706–721.
   PubMed Web of Science ®Google Scholar
• Madry H, Van Dijk CN, Mueller-Gerbl M. The basic science of the subchondral bone. Knee Surg Sports Traumatol Arthrosc. 2010;18:419–433.
   PubMed Web of Science ®Google Scholar
• Kawcak CE, McIlwraith CW, Norrdin RW, et al. The role of subchondral bone in joint disease: a review. Equine Vet J. 2001;33:120–126.
   PubMed Web of Science ®Google Scholar
• Imhof H, Sulzbacher I, Grampp S, et al. Subchondral bone and cartilage disease: a rediscovered functional unit. Invest Radiol. 2000;35:581–588.
   PubMed Web of Science ®Google Scholar
• Lopez-Ruiz E, Peran M, Cobo-Molinos J, et al. Chondrocytes extract from patients with osteoarthritis induces chondrogenesis in infrapatellar fat pad-derived stem cells. Osteoarthritis Cartilage. 2013;21:246–258.
   PubMed Web of Science ®Google Scholar
• Gomoll AH, Farr J, Gillogly SD, et al. Surgical management of articular cartilage defects of the knee. J Bone Joint Surg Am. 2010;20;92:2470–2490.
   Google Scholar
• Rodriguez-Merchan EC. The treatment of cartilage defects in the knee joint: microfracture, mosaicplasty, and autologous chondrocyte implantation. Am J Orthop (Belle Mead NJ). 2012;41:236–239.
   PubMedGoogle Scholar
• Stock UA, Vacanti JP. Tissue engineering: current state and prospects. Annu Rev Med. 2001;52:443–451.
   PubMed Web of Science ®Google Scholar
• Langer R, Vacanti JP. Tissue engineering. Science. 1993;14;260:920–926.
   Web of Science ®Google Scholar
• Malinin TI. Method for production of large numbers of cartilage cells with phenotype retention. US2015344847A1. 2015.
   Google Scholar
• A method for treating osteoarthritis and cartilage defects compositions for cell therapy. CN105106238A. 2015.
   Google Scholar
• Chabio & Diostech CO LDT. Cell therapy product for cartilage damage comprising collagen, hyaluronic acid derivative and mammalian umbilical cord-derived stem cells. KR20130009651A. 2013.
   Google Scholar
• Nutech Medical INC. Placental membrane preparations and methods of making and using same for regenerating cartilage and spinal intervertebral discs. US2015328264. 2015.
   Google Scholar
• Yufeng L, Guangqian Z .Osteochondral cell-based method for rapidly screening orthopaedic drugs. CN104673875A. 2015.
   Google Scholar
• Charles A, Ilyas K. Methods for cartilage repair using TFGbeta and FGF. WO2011161437A1. 2011.
   Google Scholar
• Guo F. XBP1S (X-box binding protein 1 spiced), novel transcription factor for promoting cartilage repair. CN102321574B. 2011.
   Google Scholar
• Dawei C, Qing J. Application of compound for preparing drugs treating osteoarthritis. CN103622939A. 2014.
   Google Scholar
• Okumura T Use of ep4 receptor antagonists in the treatment of cartilage disease. WO2014148053A1. 2014.
   Google Scholar
• Yan C, Yanqiang Z, Chun T, et al. Medical Injectable PLGA porous composite microsphere preparation embedded with BMP-2 containing particles and preparation method and application thereof. CN104436298A. 2015.
   Google Scholar
• Safran CB, Farach-Carson MC, Xinqiao J, et al. Injectable delivery system for heparan sulfate binding growth factors. WO2012125914A1. 2012.
   Google Scholar
• D’lima D, Grogan S. Colwell C. Electrospinning of cartilage and meniscus matrix polymers. WO2015138970A1. 2015.
   Google Scholar
• Xiaogang W, Yanqin W, Xiaohong W, et al. Preparation method of carbon dot/polyacrylamide cartilage substitute material with fluorescent tracking performance. CN104177541A. 2014.
   Google Scholar
• Gang W, et al. Univ South China Tech. Osteochondral three-dimensional stent with regular interpenetrating network structure and preparation method thereof. CN103893818B. 2015.
   Google Scholar
• Nukavarapu SP, Laurencin CT, Amini AR, et al. Gradient porous scaffolds. US20140178455A1. 2014.
   Google Scholar
• Castro NJ, O’brien CM, Zhang LG. Biomimetic biphasic 3D nanocomposite scaffold for osteochondral regeneration. WO2014149279A1. 2014.
   Google Scholar
• Xiaojun Y, Paul L Biphasic osteochondral scaffold for reconstruction of articular cartilage. US20150110846A1. 2015.
   Google Scholar
• Hideki Y, et al. Scaffold-free self-organizing three-dimensional artificial tissue and artificial bone composite for osteochondral regeneration. EP2799093A1. 2014.
   Google Scholar
• Vivoscript INC. Methods for repairing cartilage damage. WO2015188020. 2015.
   Google Scholar
• Shi Y, Barrett C. ALLOSOURCE perforated osteochondral allograft compositions. US9168140B2. 2015.
   Google Scholar
• Rosenwasser MP, Ateshian GA, Hung CT, et al. Customized bendable osteochondral allografts. WO2015138652A1. 2015.
   Google Scholar
• Osiris Therapeutics Inc. Porated cartilage products. US20150140057A1. 2015.
   Google Scholar
• Seo SJ, Mahapatra C, Singh RK, et al. Strategies for osteochondral repair: focus on scaffolds. J Tissue Eng. 2014;5:2041731414541850.
   Google Scholar
• Minas T, Gomoll AH, Solhpour S, et al. Autologous chondrocyte implantation for joint preservation in patients with early osteoarthritis. Clin Orthop Relat Res. 2010;468:147–157.
   PubMed Web of Science ®Google Scholar
• Demoor M, Maneix L, Ollitrault D, et al. Deciphering chondrocyte behaviour in matrix-induced autologous chondrocyte implantation to undergo accurate cartilage repair with hyaline matrix. Pathol Biol. 2012;60:199–207.
   PubMed Web of Science ®Google Scholar
• Basad E, Wissing FR, Fehrenbach P, et al. Matrix-induced autologous chondrocyte implantation (MACI) in the knee: clinical outcomes and challenges. Knee Surg Sports Traumatol Arthrosc. 2015;23:3729–3735.
   PubMed Web of Science ®Google Scholar
• Ma B, Leijten JC, Wu L, et al. Gene expression profiling of dedifferentiated human articular chondrocytes in monolayer culture. Osteoarthritis Cartilage. 2013;21:599–603.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143–147.
   PubMed Web of Science ®Google Scholar
• Grassel S, Lorenz J. Tissue-engineering strategies to repair chondral and osteochondral tissue in osteoarthritis: use of mesenchymal stem cells. Curr Rheumatol Rep. 2014;16:452.
   PubMed Web of Science ®Google Scholar
• Lee RH, Kim B, Choi I, et al. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem. 2004;14:311–324.
   PubMed Web of Science ®Google Scholar
• Maxson S, Lopez EA, Yoo D, et al. Concise review: role of mesenchymal stem cells in wound repair. Stem Cells Transl Med. 2012;1:142–149.
   PubMed Web of Science ®Google Scholar
• Parolini O, Caruso M. Review: preclinical studies on placenta-derived cells and amniotic membrane: an update. Placenta. 2011;32(Suppl 2):S186–S195.
   Google Scholar
• Lee K, Silva EA, Mooney DJ. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments. J R Soc Interface. 2011;8:153–170.
   PubMed Web of Science ®Google Scholar
• Peran M, Ruiz S, Kwiatkowski W, et al. Activin/BMP2 chimeric ligands direct adipose-derived stem cells to chondrogenic differentiation. Stem Cell Res. 2013;10:464–476.
   PubMed Web of Science ®Google Scholar
• Esquivies L, Blackler A, Peran M, et al. Designer nodal/BMP2 chimeras mimic nodal signaling, promote chondrogenesis, and reveal a BMP2-like structure. J Biol Chem. 2014;289:1788–1797.
   PubMed Web of Science ®Google Scholar
• Jimenez G, Lopez-Ruiz E, Kwiatkowski W, et al. Activin A/BMP2 chimera AB235 drives efficient redifferentiation of long term cultured autologous chondrocytes. Sci Rep. 2015;5:16400.
   PubMed Web of Science ®Google Scholar
• Moshaverinia A, Ansari S, Chen C, et al. Co-encapsulation of anti-BMP2 monoclonal antibody and mesenchymal stem cells in alginate microspheres for bone tissue engineering. Biomaterials. 2013;34:6572–6579.
   PubMed Web of Science ®Google Scholar
• Kawakami Y, Rodriguez-Leon J, Izpisua Belmonte JC. The role of TGFbetas and Sox9 during limb chondrogenesis. Curr Opin Cell Biol. 2006;18:723–729.
   PubMed Web of Science ®Google Scholar
• Renard E, Poree B, Chadjichristos C, et al. Sox9/Sox6 and Sp1 are involved in the insulin-like growth factor-I-mediated upregulation of human type II collagen gene expression in articular chondrocytes. J Mol Med (Berl). 2012;90:649–666.
   PubMed Web of Science ®Google Scholar
• Lefebvre V, Behringer RR, De Crombrugghe B. L-Sox5, Sox6 and Sox9 control essential steps of the chondrocyte differentiation pathway. Osteoarthritis Cartilage. 2001;9(Suppl A):S69–75.
   PubMed Web of Science ®Google Scholar
• Guo FJ, Xiong Z, Lu X, et al. ATF6 upregulates XBP1S and inhibits ER stress-mediated apoptosis in osteoarthritis cartilage. Cell Signal. 2014;26:332–342.
   PubMed Web of Science ®Google Scholar
• Vojinovic J, Damjanov N. HDAC inhibition in rheumatoid arthritis and juvenile idiopathic arthritis. Mol Med. 2011;17:397–403.
   PubMed Web of Science ®Google Scholar
• Shuttleworth SJ, Bailey SG, Townsend PA. Histone deacetylase inhibitors: new promise in the treatment of immune and inflammatory diseases. Curr Drug Targets. 2010;11:1430–1438.
   PubMed Web of Science ®Google Scholar
• Chen WP, Bao JP, Tang JL, et al. Trichostatin A inhibits expression of cathepsins in experimental osteoarthritis. Rheumatol Int. 2011;31:1325–1331.
   PubMed Web of Science ®Google Scholar
• Nasu Y, Nishida K, Miyazawa S, et al. Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model. Osteoarthritis Cartilage. 2008;16:723–732.
   PubMed Web of Science ®Google Scholar
• Chen WP, Bao JP, Hu PF, et al. Alleviation of osteoarthritis by Trichostatin A, a histone deacetylase inhibitor, in experimental osteoarthritis. Mol Biol Rep. 2010;37:3967–3972.
   PubMed Web of Science ®Google Scholar
• Li X, Ellman M, Muddasani P, et al. Prostaglandin E2 and its cognate EP receptors control human adult articular cartilage homeostasis and are linked to the pathophysiology of osteoarthritis. Arthritis Rheum. 2009;60:513–523.
   PubMed Web of Science ®Google Scholar
• Attur M, Al-Mussawir HE, Patel J, et al. Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor. J Immunol. 2008;181:5082–5088.
   PubMed Web of Science ®Google Scholar
• Zhu J, Marchant RE. Design properties of hydrogel tissue-engineering scaffolds. Expert Rev Med Devices. 2011;8:607–626.
   PubMed Web of Science ®Google Scholar
• Darling EM, Athanasiou KA. Rapid phenotypic changes in passaged articular chondrocyte subpopulations. J Orthop Res. 2005;23:425–432.
   PubMed Web of Science ®Google Scholar
• Puppi D, Piras AM, Chiellini F, et al. Optimized electro- and wet-spinning techniques for the production of polymeric fibrous scaffolds loaded with bisphosphonate and hydroxyapatite. J Tissue Eng Regen Med. 2011;5:253–263.
   PubMed Web of Science ®Google Scholar
• Bajaj P, Schweller RM, Khademhosseini A, et al. 3D biofabrication strategies for tissue engineering and regenerative medicine. Annu Rev Biomed Eng. 2014;16:247–276.
   PubMed Web of Science ®Google Scholar
• Woodfield TB, Malda J, De Wijn J, et al. Design of porous scaffolds for cartilage tissue engineering using a three-dimensional fiber-deposition technique. Biomaterials. 2004;25:4149–4161.
   PubMed Web of Science ®Google Scholar
• Castro NJ, Patel R, Zhang LG. Design of a novel 3D printed bioactive nanocomposite scaffold for improved osteochondral regeneration. Cell Mol Bioeng. 2015;8:416–432.
   PubMed Web of Science ®Google Scholar
• Lee CH, Cook JL, Mendelson A, et al. Regeneration of the articular surface of the rabbit synovial joint by cell homing: a proof of concept study. Lancet. 2010;376:440–448.
   PubMed Web of Science ®Google Scholar
• Yang F, Murugan R, Wang S, et al. Electrospinning of nano/micro scale poly(L-lactic acid) aligned fibers and their potential in neural tissue engineering. Biomaterials. 2005;26:2603–2610.
   PubMed Web of Science ®Google Scholar
• Izadifar Z, Chen X, Kulyk W. Strategic design and fabrication of engineered scaffolds for articular cartilage repair. J Funct Biomater. 2012;3:799–838.
   PubMedGoogle Scholar
• Spiller KL, Maher SA, Lowman AM. Hydrogels for the repair of articular cartilage defects. Tissue Eng Part B Rev. 2011;17:281–299.
   PubMed Web of Science ®Google Scholar
• Moutos FT, Guilak F. Composite scaffolds for cartilage tissue engineering. Biorheology. 2008;45:501–512.
   PubMed Web of Science ®Google Scholar
• Levingstone TJ, Thompson E, Matsiko A, et al. Multi-layered collagen-based scaffolds for osteochondral defect repair in rabbits. Acta Biomater. 2016;32:149–160.
   PubMed Web of Science ®Google Scholar
• Klein TJ, Malda J, Sah RL, et al. Tissue engineering of articular cartilage with biomimetic zones. Tissue Eng Part B Rev. 2009;15:143–157.
   PubMed Web of Science ®Google Scholar
• Nguyen LH, Kudva AK, Saxena NS, et al. Engineering articular cartilage with spatially-varying matrix composition and mechanical properties from a single stem cell population using a multi-layered hydrogel. Biomaterials. 2011;32:6946–6952.
   PubMed Web of Science ®Google Scholar
• Silva JM, Georgi N, Costa R, et al. Nanostructured 3D constructs based on chitosan and chondroitin sulphate multilayers for cartilage tissue engineering. PLoS One. 2013;8:e55451.
   PubMed Web of Science ®Google Scholar
• Ainola M, Tomaszewski W, Ostrowska B, et al. A bioactive hybrid three-dimensional tissue-engineering construct for cartilage repair. J Biomater Appl. 2016;30:873–885.
   PubMed Web of Science ®Google Scholar
• Martin I, Miot S, Barbero A, et al. Osteochondral tissue engineering. J Biomech. 2007;40:750–765.
   PubMed Web of Science ®Google Scholar
• Oliveira JM, Rodrigues MT, Silva SS, et al. Novel hydroxyapatite/chitosan bilayered scaffold for osteochondral tissue-engineering applications: scaffold design and its performance when seeded with goat bone marrow stromal cells. Biomaterials. 2006;27:6123–6137.
   PubMed Web of Science ®Google Scholar
• Jiang J, Tang A, Ateshian GA, et al. Bioactive stratified polymer ceramic-hydrogel scaffold for integrative osteochondral repair. Ann Biomed Eng. 2010;38:2183–2196.
   PubMed Web of Science ®Google Scholar
• You M, Peng G, Li J, et al. Chondrogenic differentiation of human bone marrow mesenchymal stem cells on polyhydroxyalkanoate (PHA) scaffolds coated with PHA granule binding protein PhaP fused with RGD peptide. Biomaterials. 2011;32:2305–2313.
   PubMed Web of Science ®Google Scholar
• Ma Z, Gao C, Gong Y, et al. Cartilage tissue engineering PLLA scaffold with surface immobilized collagen and basic fibroblast growth factor. Biomaterials. 2005;26:1253–1259.
   PubMed Web of Science ®Google Scholar
• Miller ED, Li K, Kanade T, et al. Spatially directed guidance of stem cell population migration by immobilized patterns of growth factors. Biomaterials. 2011;32:2775–2785.
   PubMed Web of Science ®Google Scholar
• Yang Q, Peng J, Guo Q, et al. A cartilage ECM-derived 3-D porous acellular matrix scaffold for in vivo cartilage tissue engineering with PKH26-labeled chondrogenic bone marrow-derived mesenchymal stem cells. Biomaterials. 2008;29:2378–2387.
   PubMed Web of Science ®Google Scholar
• Cheng CW, Solorio LD, Alsberg E. Decellularized tissue and cell-derived extracellular matrices as scaffolds for orthopaedic tissue engineering. Biotechnol Adv. 2014;32:462–484.
   PubMed Web of Science ®Google Scholar
• Gong YY, Xue JX, Zhang WJ, et al. A sandwich model for engineering cartilage with acellular cartilage sheets and chondrocytes. Biomaterials. 2011;32:2265–2273.
   PubMed Web of Science ®Google Scholar
• Lu H, Hoshiba T, Kawazoe N, et al. Cultured cell-derived extracellular matrix scaffolds for tissue engineering. Biomaterials. 2011;32:9658–9666.
   PubMed Web of Science ®Google Scholar
• Levorson EJ, Hu O, Mountziaris PM, et al. Cell-derived polymer/extracellular matrix composite scaffolds for cartilage regeneration, part 2: construct devitalization and determination of chondroinductive capacity. Tissue Eng Part C Methods. 2014;20:358–372.
   PubMed Web of Science ®Google Scholar
• Tang C, Xu Y, Jin C, et al. Feasibility of autologous bone marrow mesenchymal stem cell-derived extracellular matrix scaffold for cartilage tissue engineering. Artif Organs. 2013;37:E179–90.
   Google Scholar
• Marcacci M, Filardo G, Kon E. Treatment of cartilage lesions: what works and why? Injury. 2013;44(Suppl 1):S11–15.
   PubMedGoogle Scholar
• Marcacci M. Study for the treatment of knee chondral and osteochondral lesions. ClinicalTrials.gov Identifier: NCT01282034. 2014.
   Google Scholar
• Assor M .Transplantation of bone marrow stem cells stimulated by proteins scaffold to heal defects articular cartilage of the knee. ClinicalTrials.gov Identifier: NCT01159899. 2014.
   Google Scholar
• Stanish W. A study to evaluate the safety of augment™ bone graft. ClinicalTrials.gov Identifier:NCT01290991. 2013.
   Google Scholar
• Lehman RC, Davidson PA Evaluation of an acellular osteochondral graft for cartilage lesions pilot trial (EAGLE pilot) ClinicalTrials.gov Identifier: NCT01183637. 2015.
   Google Scholar
• Dobner P Safety and efficacy study of HYTOP® in the treatment of focal chondral defects. ClinicalTrials.gov Identifier: NCT01791062. 2015.
   Google Scholar
• Wong I Efficacy of BST-CarGel in treating chondral lesions of the hip. ClinicalTrials.gov Identifier: NCT02540200. 2015.
   Google Scholar
• Gobbi A HyaloFAST trial for repair of articular cartilage in the knee (FastTRACK). ClinicalTrials.gov Identifier: NCT02659215. 2016.
   Google Scholar
• Giannini S “One-step” bone marrow mononuclear cell transplantation in talar osteochondral lesions (BMDC).ClinicalTrials.gov Identifier: NCT02005861. 2015.
   Google Scholar
• Kon E Evaluation of the Agili-C biphasic implant in the knee joint. ClinicalTrials.gov Identifier: NCT01471236. 2014.
   Google Scholar
• Smith & Nephew, Inc. Smith & Nephew’s European Trufit study. ClinicalTrials.gov Identifier: NCT01246635. 2015.
   Google Scholar
• Ringdahl E, Pandit S. Treatment of knee osteoarthritis. Am Fam Physician. 2011;83(1):1287–1292.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Merchan EC. Intra-articular injections of hyaluronic acid and other drugs in the knee joint. Hss J. 2013;9:180–182.
   PubMedGoogle Scholar
• Glennon-Alty L, Williams R, Dixon S, et al. Induction of mesenchymal stem cell chondrogenesis by polyacrylate substrates. Acta Biomater. 2013;9:6041–6051.
   PubMed Web of Science ®Google Scholar
• Kim SH, Jung Y. TGF-beta3 encapsulated PLCL scaffold by a supercritical CO2-HFIP co-solvent system for cartilage tissue engineering. J Control Release. 2015;28;206:101–107.
   Web of Science ®Google Scholar
• Zheng D, Dan Y, Yang SH, et al. Controlled chondrogenesis from adipose-derived stem cells by recombinant transforming growth factor-beta3 fusion protein in peptide scaffolds. Acta Biomater. 2015;11:191–203.
   PubMed Web of Science ®Google Scholar
• Kon E, Filardo G, Di Martino A, et al. Clinical results and MRI evolution of a nano-composite multilayered biomaterial for osteochondral regeneration at 5 years. Am J Sports Med. 2014;42:158–165.
   PubMed Web of Science ®Google Scholar
• Bedi A, Foo LF, Williams RJ 3rd, et al. The maturation of synthetic scaffolds for osteochondral donor sites of the knee: an MRI and T2-mapping analysis. Cartilage. 2010;1:20–28.
   PubMed Web of Science ®Google Scholar
• Carmont MR, Carey-Smith R, Saithna A, et al. Delayed incorporation of a TruFit plug: perseverance is recommended. Arthroscopy. 2009;25:810–814.
   PubMed Web of Science ®Google Scholar